Comprehensive Immune Subtyping and Multi-Omics Profiling of the Tumor Microenvironment in Colorectal Cancer: Implications for Prognosis and Personalized Immunotherapy
This research integrates TME subtyping, risk modeling, single-cell analysis, and microbiome profiling to advance CRC prognosis and precision therapy, emphasizing personalized strategies for better outcomes.
Authors
- Zhiwei Li (ORCID: https://orcid.org/0000-0002-2870-7265)
- Shengxian Fan (ORCID: https://orcid.org/0000-0002-4379-6833)
- Bailing Zhou (ORCID: https://orcid.org/0000-0002-4824-347X)
- Hao Wang (ORCID: https://orcid.org/0000-0003-0214-7615)
- Jihua Wang (ORCID: https://orcid.org/0000-0002-2109-8807)
Institutions
- Taizhou Second People's Hospital (CN)
- Nanjing Drum Tower Hospital (CN)
- Institute of Biophysics (CN)
- Dezhou University (CN)
Publication Details
- Journal
- Current Cancer Drug Targets
- Published
- 2025-09-26
- DOI
- https://doi.org/10.2174/0115680096395386250910130110
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05